Ativa halts NK drug development, GC Cell plunges; business restructuring under review
Predicted impact: Medium
Partner halts NK drug development; GC Cell fell sharply, restructuring under review.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.